Form 8-K - Current report:
SEC Accession No. 0001439222-25-000076
Filing Date
2025-07-08
Accepted
2025-07-08 07:01:27
Documents
12
Period of Report
2025-07-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K agio-20250703.htm   iXBRL 8-K 33073
  Complete submission text file 0001439222-25-000076.txt   148693

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20250703.xsd EX-101.SCH 1764
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20250703_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20250703_pre.xml EX-101.PRE 12496
14 EXTRACTED XBRL INSTANCE DOCUMENT agio-20250703_htm.xml XML 2720
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 251109513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)